The significance and expectations of HIV cure research among people living with HIV in Australia.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2020
Historique:
received: 31 10 2019
accepted: 12 02 2020
entrez: 5 3 2020
pubmed: 5 3 2020
medline: 18 6 2020
Statut: epublish

Résumé

Most people living with HIV (PLHIV) with reliable access to antiretroviral treatment (ART) have a life expectancy similar to uninfected populations. Despite this, HIV can negatively affect their social and psychological wellbeing. This study aimed to enhance understanding of the expectations PLHIV hold for HIV cure research and the implications this has for HIV cure research trials. We interviewed 20 Australian PLHIV about their expectations for HIV cure research outcomes and the impact a potential cure for HIV may have on their everyday lives. Data were analysed thematically, using both inductive and deductive approaches. The significance of a cure for HIV was expressed by participants as something that would offer relief from their sense of vigilance or uncertainty about their health into the future. A cure was also defined in social terms, as alleviation from worry about potential for onward HIV transmission, concerns for friends and family, and the negative impact of HIV-related stigma. Participants did not consider sustained medication-free viral suppression (or remission) as a cure for HIV because this did not offer certainty in remaining virus free in a way that would alleviate these fears and concerns. A cure was seen as complete elimination of HIV from the body. There is an ethical need to consider the expectations of PLHIV in design of, and recruitment for, HIV cure-related research. The language used to describe HIV cure research should differentiate the long-term aspiration of achieving complete elimination of HIV from the body and possible shorter-term therapeutic advances, such as achieving medication free viral suppression.

Identifiants

pubmed: 32130262
doi: 10.1371/journal.pone.0229733
pii: PONE-D-19-30411
pmc: PMC7055878
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0229733

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

J Virus Erad. 2015 Oct;1:250-256
pubmed: 26866059
JAMA. 2019 Feb 5;321(5):451-452
pubmed: 30629090
BMC Med. 2016 Jun 22;14(1):94
pubmed: 27334606
J Int AIDS Soc. 2011 Jan 24;14:4
pubmed: 21255462
Lancet HIV. 2019 Apr;6(4):e259-e268
pubmed: 30885693
Am J Public Health. 2017 Jun;107(6):863-869
pubmed: 28426316
HIV Med. 2017 Feb;18(2):73-79
pubmed: 27167600
J Virus Erad. 2017 Apr 1;3(2):82-84
pubmed: 28435691
AIDS Res Hum Retroviruses. 2015 Jan;31(1):78-84
pubmed: 25427547
BMC Public Health. 2018 Apr 20;18(1):527
pubmed: 29678156
Ann Intern Med. 2013 Oct 1;159(7):490-1
pubmed: 23938938
Sociol Health Illn. 2016 Mar;38(3):411-25
pubmed: 26498141
Psychooncology. 2013 Jul;22(7):1630-8
pubmed: 23060271
Nurse Res. 2006 Jul 1;13(4):84
pubmed: 27702218
J Infect Dis. 2019 Jul 2;220(Supplement_1):S5-S6
pubmed: 30779842
J Acquir Immune Defic Syndr. 2014 Nov 1;67(3):e110-1
pubmed: 25314254
AIDS. 2015 Jan 14;29(2):248-50
pubmed: 25532611
Infection. 2016 Apr;44(2):151-8
pubmed: 26471511
Trends Microbiol. 2014 Oct;22(10):547-9
pubmed: 25280965
Qual Health Res. 2005 Nov;15(9):1277-88
pubmed: 16204405
N Engl J Med. 2016 Sep 1;375(9):830-9
pubmed: 27424812
Nat Med. 2016 Aug;22(8):839-50
pubmed: 27400264
Patient. 2014;7(4):387-95
pubmed: 25034612
Arch Sex Behav. 2018 Oct;47(7):2061-2069
pubmed: 29149399
BMC Public Health. 2018 Feb 13;18(1):245
pubmed: 29439706
BMC Med Ethics. 2015 Mar 27;16:18
pubmed: 25885856
J Med Ethics. 2018 Apr;44(4):270-276
pubmed: 29127137
PLoS Pathog. 2014 Nov 13;10(10):e1004473
pubmed: 25393648
J Virus Erad. 2017 Jan 1;3(1):40-50.e21
pubmed: 28275457
Sex Health. 2017 Feb;14(1):111-118
pubmed: 27977386
PLoS One. 2018 Aug 24;13(8):e0202647
pubmed: 30142171
AIDS Res Hum Retroviruses. 2018 Jan;34(1):67-79
pubmed: 28562069
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
Med Soc (Berkeley). 1996;:1-466
pubmed: 11619509
Glob Qual Nurs Res. 2015 Aug 14;2:2333393615597674
pubmed: 28462313
AIDS Res Hum Retroviruses. 2018 Jan;34(1):56-66
pubmed: 29198134
J Infect Dis. 2019 Nov 19;:
pubmed: 31742347
J Behav Med. 2017 Jun;40(3):434-444
pubmed: 27904976

Auteurs

Jennifer Power (J)

Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.

Gary W Dowsett (GW)

Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.
Centre for Social Research in Health, UNSW Australia, Sydney, Australia.

Andrew Westle (A)

Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.

Joseph D Tucker (JD)

Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America.
Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, United Kingdom.

Sophie Hill (S)

Centre for Health Communication and Participation, School of Psychology and Public Health, La Trobe University, Melbourne, Australia.

Jeremy Sugarman (J)

Berman Institute of Bioethics, Johns Hopkins University, Baltimore, Maryland, United States of America.
Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.

Sharon R Lewin (SR)

The Peter Doherty Institute for Infection and Immunity, University of Melbourne and Royal Melbourne Hospital, Melbourne, Australia.
Department of Infectious Diseases, Alfred Health and Monash University, Melbourne, Australia.

Graham Brown (G)

Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.
Centre for Social Research in Health, UNSW Australia, Sydney, Australia.

Jayne Lucke (J)

Australian Research Centre in Sex, Health and Society, La Trobe University, Melbourne, Australia.
School of Public Health, The University of Queensland, Brisbane, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH